Open main menu
Search Ctrl + K
Sign up for free
Loading...
Xenetic Biosciences, Inc.
Watch
Pharmaceutical Preparations
NASDAQ.XBIO
945 Concord St., Framingham, MA, 01701
Categorized
Chronological
Ownership by Owner
Insider Transactions
Institutional Owners
Filings by Form Type
Transcripts
Your Highlights
Search Within Documents
Key Exhibits
Articles & Bylaws
Indentures
Material contracts
Plans of Reorganization
Underwriting Agreements
External Links
Google Finance
SEC EDGAR
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Financials
10-Q
Quarterly Filing
13 Aug 24
10-Q
Quarterly Filing
09 May 24
10-K/A
Fiscal Year 2023
26 Apr 24
10-K
Fiscal Year 2023
21 Mar 24
10-Q
Quarterly Filing
09 Nov 23
10-Q
Quarterly Filing
10 Aug 23
10-Q
Quarterly Filing
11 May 23
Prospectuses and Registrations
25-NSE
Notification Filed By National Securities Exchanges Of The Removal From Listing And Registration Of Matured, Redeemed Or Retired Securities.
18 Jul 24
S-8
Registration Of Securities To Be Offered To Employees In Employee Benefit Plans.
30 Dec 21
424B5
Prospectus Filed Pursuant To Rule 424(b)(5).
19 Nov 21
S-3/A
Amendment To The S-3 Registration Statement.
20 Oct 21
424B5
Prospectus Filed Pursuant To Rule 424(b)(5).
11 Dec 20
S-8
Registration Of Securities To Be Offered To Employees In Employee Benefit Plans.
01 Apr 20
8-A12B
Registration Of Certain Classes Of Securities Under Section 12(b).
22 Jul 19
Other
ARS
Scanned Paper Annual Report Submission.
13 Nov 23
10-K/A
Amended Annual Report Under Section 13 Or 15(d) Of The Exchange Act.
28 Apr 23
D
Notice Of An Exempt Offering Of Securities Under Regulation D.
13 Oct 22
D
Notice Of An Exempt Offering Of Securities Under Regulation D.
04 May 22
10-K/A
Amended Annual Report Under Section 13 Or 15(d) Of The Exchange Act.
28 Apr 22
EFFECT
Notice Of Effectiveness For A Previously Filed Sec Document.
22 Oct 21
CORRESP
Correspondence With The Sec.
20 Oct 21
Proxies
DEF 14A
Definitive Proxy Statement Provided In Advance Of A Shareholder Meeting.
13 Nov 23
DEF 14A
Definitive Proxy Statement Provided In Advance Of A Shareholder Meeting.
17 Oct 22
DEFA14A
Additional Definitive Proxy Soliciting Materials And Rule 14(a)(12) Material.
17 Oct 22
PRE 14A
Preliminary Proxy Statement Not Yet Definitive.
03 Oct 22
DEFA14A
Additional Definitive Proxy Soliciting Materials And Rule 14(a)(12) Material.
02 Dec 21
DEF 14A
Definitive Proxy Statement Provided In Advance Of A Shareholder Meeting.
15 Oct 21
DEF 14A
Definitive Proxy Statement Provided In Advance Of A Shareholder Meeting.
13 Oct 20
Ownership
4
Parslow James F
21 Jun 24
SC 13D/A
Amended Statement Of Beneficial Ownership Of More Than 5%.
18 Mar 24
3
Mizrahy Moshe
18 Dec 23
4
Mizrahy Moshe
18 Dec 23
4
Lockshin Curtis
13 Dec 23
4
Parslow James F
13 Dec 23
4
Eisenberg Jeffrey F
13 Dec 23
News
8-K
Results Of Operations And Financial Condition, Financial Statements And Exhibits
14 Aug 24
8-K
Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers: Compensatory Arrangements Of Certain Officers
21 Jun 24
8-K
Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers: Compensatory Arrangements Of Certain Officers, Regulation Fd Disclosure, Financial Statements And Exhibits
22 May 24
8-K
Results Of Operations And Financial Condition, Financial Statements And Exhibits
10 May 24
8-K
Results Of Operations And Financial Condition, Financial Statements And Exhibits
22 Mar 24
8-K
Regulation Fd Disclosure
12 Feb 24
8-K
Submission Of Matters To A Vote Of Security Holders
08 Dec 23